Sinopharm Group 

€11.3
+€0+0% Friday 07:10

Statistik

Dagens högsta
11.3
Dagens lägsta
11.3
52V högsta
-
52V lägsta
-
Volym
0
Genomsnittlig volym
-
Marknadsvärde
7.5B
P/E förhållande
6.5
Utdelningsavkastning
5.05%
Utdelning
0.57

Kommande

Utdelningar

5.05%Utdelningsavkastning
10-års tillväxt
13.69%
5 års tillväxt
8.54%
3 års tillväxt
8.65%
1 års tillväxt
8.68%

Inkomster

23AugFörväntad
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0.69
1.04
1.4
1.75
Förväntad EPS
1.47997447536
Verklig EPS
1.2762098736799998

Människor följer också

Den här listan baseras på bevakningslistorna för människor på Stock Events som följer X2S1.F. Det är inte en investeringsrekommendation.

Konkurrenter

Denna lista är en analys baserad på nyliga marknadshändelser. Det är inte en investeringsrekommendation.

Om

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more...
VD
Mr. Wanyong Lian
Anställda
113635
Land
US
ISIN
US82937K1016
WKN
000A2P3LX

Noteringar